Shares of Cardinal Health, Inc. (CAH) have dropped -11.2% since the company’s Sep-19 earnings report. Over the past 12 fiscal quarters, Cardinal Health, Inc. (NYSE:CAH) has topped consensus earnings estimates in 11 quarters (91%), missed earnings in 1 quarters (8%), whereas at 0 occasion EPS met analyst expectations. CAH last reported earnings on November 08, 2018 when it released Sep-18 results that exceeded expectations. The company raked in $1.29 per share, -93.51% change on the same period last year. That was better than consensus for $1.08. Revenue for the recent quarter stood at $35.21 billion, up 8% on last year and above the $33.65 billion predicted by analysts. For this quarter, Wall Street analysts forecast revenue in a range of $36.12 billion to $36.77 billion, which should be compared with $35.74 billion generated last year. EPS is seen in a range of $1 to $1.35, against the $1.35 reported a year ago.

CAH’s 50 day simple moving average (SMA 50) price is $50.73 and its 200-day simple moving average (SMA 200) price is $52.94. The company’s stock currently has a total float of 297M shares. Its weekly volatility is hovering around 1.71% and felt 3.02% volatility in price over a month. On the upside, the share price will test short term resistance at around $48.89. On a downside, the stock is likely to find some support, which begins at $47.8. The failure to get near-term support could push it to $47.19.

Separately, it has been reported that multiple insider activity took place at Cardinal Health, Inc. (CAH). SVP & Chief Accounting Officer Laws Stuart G sold 804 shares for $6,296 in transaction occurred on 2018/11/13. After making this transaction, the SVP & Chief Accounting Officer owns a direct stake of 44,662 shares, worth $304,852, as per the last closing price. On 2018/08/20 Giacomin Jon L, CEO, Medical Segment at CAH, dumped 2,890 shares at an average price of $51.95 per share. The selling total is valued at $3,517,810.

CEO, Medical Segment, Giacomin Jon L had divested 7,995 shares for $55,048 through a trade on 2018/02/20. Following this activity, the insider holds 549,896 shares worth $2,665,424 as of recent close. Wall Street’s most bullish Cardinal Health, Inc. (NYSE:CAH) analysts are predicting the share price to blow past $82 per share during the next 12 months. The current median share price forecast by them is $55, suggesting that the stock could increase 13.59% in that time frame. The average price target of $55.93 calls for a nearly 15.51% increase in the stock price.

It had seen a negative analyst call from Leerink Partners, which downgraded the stock from Outperform to Mkt Perform on November 16. Analysts at Leerink Partners, shed their negative views on April 24 by lifting it fromMkt Perform to Outperform. The stock won favor of Argus analysts who expressed their confidence in it using an upgrade from Hold to Buy on April 02.

Moreover, it trades for 9.11 times the next 12 months of expected earnings. Also, it is trading at rather expensive levels at just over 2.5x price/book and 0.1x price/sales. Compared to others, Cardinal Health, Inc. is in a different league with regards to profitability, having net margins of 0.5%. To put some perspective around this, the industry’s average net margin is 2.89%. CAH’s ROE is 10.8%, which is also considerably worse than the industry’s ROE of 13.75%. It’s also very liquid in the near term, with a current ratio of 1.1. The stock has a debt/capital of 1.52.

Cardinal Health, Inc. (NYSE:CAH) sank as low as $47.66 Wednesday before getting settled at $48.42. The 1.66 percent increase called for market cap to move at $14.43B. The price went up as high as $47.66 before retreating. Trading activity significantly weakened as the volume at ready counter decreased to 3,132,602 shares versus 3,274,010 in average daily trading volume over the past 20 days. So far this year, the volume has averaged about 2,978,073 shares. The stock is now 14.82% above against its bear-market low of $42.17 on December 26, 2018. It has retreated -56.44% since it’s 52-week high of $75.75 reached in January. Now the market price is down -33.29% on the year and up 8.57% YTD.